Tuesday, October 6, 2015
October marks the second annual National Substance Abuse Prevention Month an observance to highlight the vital role of substance abuse prevention in both individual and community health and to remember those who have lost their lives to alcohol and drugs. According the recently released 2011 National Survey on Drug Use and Health, 20.6 million Americans over the age of 12 are addicted to alcohol and drugs; 14.1 million alcohol, 3.9 million illicit drugs, no alcohol and 2.6 million, alcohol and illicit drugs. Plain and simple, underage drinking, alcohol and drug dependence, non-medical use of prescription drugs, abuse of over-the-counter medications, and illicit drug use take a devastating toll on our families and in our communities. For example, young Americans aged 12 to 20 account for 11% of the country's monthly alcohol consumption; and, approximately 23 million people aged 12 or older used illicit drugs in 2010. This abuse touches all aspects of our communities and contributes to an estimated $416 billion in crime, health care and lost productivity costs. This month let’s pay tribute to all those working to prevent substance use in our communities and rededicate ourselves to building a safer, drug-free America. For more information on Alcoholism and Drug dependence visit the National Council on Alcoholism and Drug Dependence web-site @ www.ncadd.org.
Posted by Marianne Karg at 10:31 AM
Thursday, September 10, 2015
The Centers for Disease Control and Prevention (CDC) will spend $20 million in 16 states to reduce opioid overdoses, UPI reports. Opioid overdoses have quadrupled since 1999. In 2013, more than 16,000 people died of prescription opioid overdoses in the United States, according to the CDC. In addition,more than 8,000 people died of heroin overdoses that year. Between 2002 and 2013, the rate of heroin-related overdose deaths nearly quadrupled. “The prescription drug overdose epidemic is tragic and costly, but can be reversed,” CDC Director Dr. Tom Frieden said in a news release. “Because we can protect people from becoming addicted to opioids, we must take fast action now, with real-time tracking programs, safer prescribing practices, and rapid response. Reversing this epidemic will require programs in all 50 states.” The CDC will provide funding to Arizona, California, Illinois, Kentucky, Nebraska, New Mexico, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, Tennessee, Utah, Vermont, and Wisconsin. The program will focus on improving prescription drug monitoring programs and increasing education and prevention efforts in communities. The CDC will work with doctors and health systems to help them make better decisions for patients, and to investigate the connection between prescription opioid abuse and rising heroin use. The CDC will award states between $750,000 and $1 million each year over the next four years. President Obama’s 2016 budget proposal includes a request to expand the program to all states.
Posted by Marianne Karg at 2:51 PM
Friday, August 14, 2015
People who live in areas of California with a higher density of marijuana dispensaries experience a greater number of hospitalizations involving marijuana abuse and dependence, a University of Pittsburgh Graduate School of Public Health analysis discovered. The National Institutes of Health-funded research, published online in the scientific journal Drug and Alcohol Dependence, could be informative as more states consider legalizing marijuana for medical and recreational use. It is the first analysis of the statewide impact of marijuana dispensaries on abuse and dependence, as well as the first look at population characteristics associated with marijuana-related hospitalization rates. "As marijuana is approved for medical or recreational use, we need to carefully consider where we allow dispensaries to be placed," said lead author Christina Mair, Ph.D., in a news release. "Our study indicates that there are real problems associated with a higher density of marijuana dispensaries in neighborhoods. More study and monitoring, coupled with thoughtful legislation and community discussion, will be prudent to ensure that marijuana laws have the fewest negative consequences for vulnerable populations." In 1996, California was the first state to legalize medical marijuana, allowing physicians to prescribe the drug for medical purposes. Since then, 22 states and Washington, D.C., have enacted similar laws, and four of those states also have legalized recreational use. Pennsylvania doesn't allow either, though it is considering permitting medical marijuana. Mair and her team looked at data on California hospital discharges that had either a primary or secondary medical code for marijuana dependence or abuse with at least one overnight hospital stay. The research covered 2001 through 2012, the most recent years for which consistent data were available. Hospitalizations with marijuana abuse or dependence codes increased from 17,469 in 2001 to 68,408 in 2012. More than 85 percent of marijuana-related hospitalizations were coded as abuse, rather than dependence, and 99.2 percent were secondary codes, meaning the person was primarily hospitalized for something other than marijuana. When the research team mapped the location of marijuana dispensaries and cross-referenced it with the ZIP code of each patient's home, they found that each additional dispensary per square mile in a ZIP code was associated with a 6.8 percent increase in the number of hospitalizations linked to marijuana abuse and dependence. In addition, the team found that marijuana dispensaries and hospitalizations were more likely to be located in areas with lower household incomes and lower educational attainment. "It's unclear if the marijuana dispensaries are simply locating in neighborhoods that tend to be more disadvantaged and already have underlying problems with marijuana abuse, or if the presence of the dispensaries is causing an increase in abuse and hospitalizations," Mair said. "It could be a combination of both factors." Mair noted that research on the location of marijuana dispensaries has a parallel precedent in the location of liquor stores. This gives policymakers and public health practitioners the opportunity to learn from previous studies on the health effects of density and location of liquor stores in order to design studies that can provide similar data on marijuana dispensaries.
Posted by Marianne Karg at 9:25 AM
Thursday, July 30, 2015
A growing number of obituaries of people who have died of heroin overdoses refer to their addiction, The New York Times reports. In the past, these obituaries tended to say a person died “unexpectedly” or “at home.” More families are writing candidly about their loved ones’ struggle with heroin addiction in newspapers, on Facebook and on obituary websites like Legacy.com and ObitsforLife.com. “This is part of a trend toward a greater degree of acceptance and destigmatization about issues pertaining to mental illness, including addiction,” said Dr. Jeffrey A. Lieberman, Chairman of Psychiatry at the Columbia University College of Physicians and Surgeons. He added, “If a family chooses to do this, they can have a cathartic experience that facilitates the grieving process. When the person was alive, they may have been enabling, and they couldn’t acknowledge it. But this allows them to begin that process of coming to terms with the fallibility of the family member and their own limitations in not having been able to deal with it while the person was alive.” When Wade B. Pickett Sr., 34, died of a heroin overdose, his wife, Tiffany, wrote in his obituary in the The Express-Times in Easton, Pennsylvania, “I am sorry if this obituary offends, hurts or shames some people. I hope that it might help save some people from the incredible heartache we are experiencing.” The family of Daniel Joseph Wolanski, 24, of Avon Lake, Ohio, wrote in his obituary, “Someone you know is battling addiction; if your ‘gut instinct’ says something is wrong, it most likely is.” Increasingly, drug abuse is considered a disease and a public health crisis, instead of a crime and moral failing, the article notes. While addiction obituaries do not seem to be the result of an organized effort, they are part of a movement that calls for better treatment options and changes in the criminal justice system.
Posted by Marianne Karg at 1:55 PM
Wednesday, July 15, 2015
With marijuana becoming legal in more and more states across the U.S., concerns about road safety have taken center stage. As regulations regarding how much alcohol can be safely consumed before driving have been hammered into the public eye for years, many worry that newly legalized pot rules need to be paid the same attention. However, in order for law enforcement agencies to uphold the rules governing marijuana consumption while driving, an easy system to test the amount of cannabis a driver has ingested is necessary. For that reason, many companies are working to come up with a device that can detect marijuana the way that traditional breathalyzers measure a driver's alcohol level. Prototype Cannabix Technologies Inc., a Canadian-based firm, says it is nearing the final stages of developing a ‘pot breathalyzer". The device is still only a prototype, but once it becomes available for widespread use, it could revolutionize the way that police enforce marijuana laws. Will It Be Accurate Enough? While the advent of a pot breathalyzer would be a major step forward for marijuana legalization, experts say it won't be accurate enough to be used on its own at first. The device would detect whether or not a person has THC, the psychoactive ingredient in cannabis, in their system, but probably wouldn't be able to tell just how much. More Research Needed So far, there has been no consensus regarding what amount of THC, if any, is safe for drivers. In Washington and Montana, drivers must have less than 5 nanograms/milliliter, though Pennsylvania allows just 1 ng/ml and some other states don't allow any amount of THC at all. By Laura Brooks/ benzinga
Posted by Marianne Karg at 2:43 PM
Thursday, July 2, 2015
Hawaii has become the first state to raise the legal tobacco use age to 21. The law prohibits people under the age of 21 from smoking, buying, or possessing tobacco products. The law specifically includes electronic smoking devices, defined as "any electronic product that can be used to aerosolize and deliver nicotine or other substances to the person inhaling the device, an electronic cigarette, electronic cigar, electronic cigarillo, or electronic pipe, and any cartridge or other component of the device or related product." The law was passed, in part, due to growing concerns about the prevalence of e-cigarette use among youth, noting that 29 percent of 9th and 10th graders in six Hawaii high schools report using these products at least once, and 18 percent report using them regularly, according to the state’s news release. "Partners statewide have come together to support this monumental legislation that once again puts Hawaii at the cutting edge of public health policy and protecting the health of our youth," the state's director of health, Virginia Pressler, said in a statement. Hawaii Gov. David Ige signed Senate Bill 1030 (Act 122) late last month. The law will go into effect Jan. 1. Lawmakers are also pushing to raise the tobacco use age in Washington State and California, where the state Senate passed a bill to raise the age last month, sending the legislation to the Assembly for a vote.
Posted by Marianne Karg at 4:11 PM
Thursday, June 4, 2015
Publication Date 06/02/2015 The share of U.S. workers testing positive for drugs appears to be on the rise, according to data from millions of workplace drug tests administered by one of the nation's largest medical-screening laboratories. Traces of drugs--from marijuana to methamphetamine to prescription opiates--were found in 3.9% of the 9.1 million urine tests conducted for employers by Quest Diagnostics Inc. in 2014, up from 3.7% in 2013. While the numbers might seem small, they reflect the reversal of a longtime trend of declining drug use among workers. Before 2013, positives had dropped nearly every year for 24 years, from 13.6% in 1988 to a low of 3.5% in 2012. Some of the positive results are later discarded if a worker produces a doctor's prescription for a legal drug, but the majority reflect illicit use, driven by increases in marijuana, cocaine and methamphetamine positives, said Dr. Barry Sample, director of science and technology for Quest's diagnostics employer solutions business. The upturn mirrors higher levels of substance use in the broader population, said Dr. Sample. A survey by the Department of Health and Human Services found that in 2013, 9.4% of Americans age 12 or older had used illicit drugs in the month before the survey interview was conducted, up from 9.2% in 2012 and 8.7% in 2011. Experts are unsure why drug usage is rising. Researchers haven't been able to conclusively link drug consumption to economic cycles. A 2013 paper from the Federal Reserve Bank of St. Louis, for example, concluded that "the Great Recession did not generate a clear temporary or permanent pattern in rates of substance abuse." Legalization of marijuana for medicinal and recreational use may explain some of the increase, said Mark de Bernardo, executive director of the Institute for a Drug-Free Workplace and a senior partner with management-side law firm Jackson Lewis PC. "We have a greater tolerance--and it's an unfounded tolerance--for illicit drug use," he said. The drug most commonly found in workers' samples is marijuana, which accounts for nearly half of all positive tests. Other common substances were amphetamines, oxycodones such as OxyContin, and benzodiazepines like Xanax. Twenty-three states and the District of Columbia have laws legalizing marijuana in some form. Colorado and Washington led the way in 2012, when voters approved initiatives allowing recreational use of the drug. Since then, employers have been managing a fast-moving and extremely uncertain legal landscape with drug-testing, said Jim Reidy, an attorney in the Manchester, NH office of law firm Sheehan Phinney Bass and Green PA. He has seen employers in Colorado and Washington adopt or expand testing policies, partly with the rationale that screening people out before they are hired puts firms in a less vulnerable position than firing marijuana users down the road--and possibly facing legal challenges based on the state laws. Quest's Dr. Sample noted that while test positives increased sharply in 2013 in Colorado and Washington relative to the rest of the country, in 2014 they were almost exactly in line with the national data. Use in those states may simply have "leveled off," he said. Workers in federally mandated safety-sensitive roles, such as truck drivers and pilots, are barred by federal law from using marijuana, even if it is legal where they live. Among those workers, who must undergo regular testing, Quest found that 1.7% of urine drug tests came back positive, flat with 2013. Dan Horvath, director of compliance at TransForce, Inc., a national staffing firm for truck drivers, said the company communicates regularly with drivers through safety meetings and mailers, reminding them that federal laws forbid them from smoking pot, even if their local governments allow it. "It's a lot more education material to drivers so they can't say they were not aware of testing rules." The overall Quest data reflect growing rates of some prescription drug use--and abuse. For example, even as use of many drugs has ebbed in recent years, positive tests for amphetamines, which includes prescription drugs such as Adderall, essentially doubled between 2008 and 2014. When tests show the presence of a prescription drug, the results are discarded if the individual can verify he or she was prescribed the medication by a doctor, said Dr. Sample, who added that independent studies show 65% to 80% of positive tests for legal drugs are ultimately disregarded for that reason. Employers are responding to the threat by screening for more prescription drugs. International Paper Co., a Memphis-based maker of paper and packaging, plans to add opiate derivatives like hydrocodone and oxycodone to its list. "It's preventative," said Kevin Mencke, chief counsel for employment and labor. "We're in manufacturing, so any drug abuse is a concern for us." At one location, the company experimented with using hair tests, which examine strands of hair and can detect drug use as far back as 90 days, compared with a few days or weeks for urine tests. International Paper's screening procedures found drug traces in about 1.4% of job candidates and 2% of employees tested randomly in 2014. Most employment-related drug tests are administered to job candidates, usually after an offer has been extended but before employment begins. More than half of all U.S. employers required tests for all post-offer job candidates in 2011, according to the most recent data available from the Society for Human Resource Management. In nearly all cases, employers decline to hire candidates with a verified positive result, said Mr. Reidy. Source: Dow Jones News Service By Lauren Weber
Posted by Marianne Karg at 12:15 PM
Thursday, May 21, 2015
Law enforcement officials are reporting an increase in marijuana-infused edible products being transported illegally across state lines for resale. Edibles resemble candy or home-baked products, and often have no smell that indicates they contain marijuana, The New York Times reports. Missouri troopers confiscated 400 pounds of commercially made marijuana chocolate in February. New Jersey state police seized 80 pounds of homemade marijuana sweets. Oklahoma officers seized about 40 pounds of commercial marijuana products, including taffy-like “Cheeba Chews” and bottles of marijuana-infused lemonade. In Colorado, where recreational marijuana is legal for adults 21 and over, edible marijuana products have become a popular alternative to smoking marijuana. Adults 21 and over can legally purchase marijuana edibles at state-licensed stores. Marijuana is now available in products ranging from candy to soda and granola. The amount of marijuana in edible products varies widely. In some cases, products contain levels so high that people experience extreme paranoia and anxiety. The high produced by edible products comes on more slowly than smoked marijuana. Inexperienced users may consume too much, causing severe impairment. Some experts are concerned that marijuana edibles smuggled into other states may appeal to teens. Colorado health officials are trying to find a way to prevent people from overdosing on marijuana edibles. The products have been implicated in two suicides and one murder in the past 13 months. Almost five million edibles were sold in Colorado stores last year. Marijuana edibles are also legal in Washington state, and will soon be legal in Oregon and Alaska. Edible products are also available to medical marijuana users in at least six of the 23 states with medical marijuana programs, the article notes.
Posted by Marianne Karg at 1:39 PM
Wednesday, May 6, 2015
Efforts to curb illicit drug use should target this population, researchers say THURSDAY, April 30, 2015 (HealthDay News) -- Heroin use rose among people who abuse prescription narcotic painkillers such as Oxycontin or Vicodin, a new study found. The most significant increase was a 75 percent jump in the number of white people using heroin in 2008 to 2011, researchers from Columbia University's Mailman School of Public Health revealed. "The noteworthy increase in the annual rate of heroin abuse or dependence among . . . whites parallels the significant increase in nonmedical opioid [narcotic] use during the last decade and the growing number of heroin overdose deaths described for this race and ethnic group in recent years," study leader Dr. Silvia Martins said in a university news release. Martins is an associate professor of epidemiology at the Mailman School of Public Health in New York City. Heroin use also spiked among Hispanics, according to the study. The study included information from 67,500 people who answered questions about their heroin use. These findings could help public health officials develop programs to prevent heroin use, the authors suggested. The investigators found that the use or abuse of heroin, dependence on the drug, and the risk of past use of the drug increased along with the frequency of narcotic painkiller use between 2008 and 2011. "Individuals tend to use prescription opioids as a substitute for heroin when heroin is unavailable, to augment a heroin-induced 'high,' to 'treat' withdrawal symptoms, and to curb heroin use," Martins explained in the news release. The researchers also found more frequent heroin use for Hispanics who used prescription painkillers between one and 29 days in the past year. Significant increases in heroin use were also identified among blacks and whites who used prescription painkillers between 100 and 365 days in the past year. With the exception of Hispanics, the study found that anyone who frequently used prescription narcotics was at greater risk for ever injecting heroin, as well as for heroin abuse or dependence in the past year. "This is alarming and raises concern since injection drug use among prescription opioid users can contribute to the spread of HIV . . . as well as of hepatitis C," Martins concluded. The study was published online in the journal Drug and Alcohol Dependence. More information The U.S. National Institute on Drug Abuse has more about substance abuse. SOURCE: Columbia University Mailman School of Public Health, news release, April 27, 2015
Posted by Marianne Karg at 4:51 PM
Tuesday, April 21, 2015
April 21, 2015 A drug known as “flakka” is the latest synthetic compound to raise concern among public health experts, Fox News reports. Flakka is a tweaked version of bath salts. In some cases, Flakka can cause heart palpitations and aggressive, violent behavior, the article notes. Use of the drug can affect the kidneys, leading to kidney failure or death. Flakka use has recently been reported in Florida, Ohio and Texas. The name is derived from the Spanish word “flaca,” which means “skinny.” The drug is sold in other parts of the country as “Gravel.” In Florida, Flakka contains alpha-PVP, a substance that provides an instant sense of euphoria, according to Jim Hall of Nova Southeastern University in Fort Lauderdale. The drug also gives a boost in physical strength that is similar to other stimulants, such as Ecstasy and cocaine, he said. Hospitals in South Florida are admitting 20 new patients a day for Flakka abuse, Hall told Fox News. “One of the reasons we think alpha-PVP is such a problem is because it is extremely dose-specific, and even just a little dose will give a person the desired effect they want,” he said. “Just a little more can create a number of serious adverse effects to the point the user doesn’t even know.” Flakka, which comes in crystalline rock form, can be snorted, swallowed, injected or vaped in an e-cigarette. While its effects are generally felt for three or four hours, they can continue for days. It is being sold in Florida for $5 for one-tenth of a gram. “It’s cheap like crack cocaine,” Hall said. “This is as close as we’ve come to a crack cocaine problem since 1995 in terms of the severe reactions, low prices, and that it’s available to young kids, and even homeless populations are now impacted.”
Posted by Marianne Karg at 4:14 PM
Tuesday, April 14, 2015
19 Percent of Americans Say They Take Some Sort of Drug Daily to Help Them Relax A new survey finds almost 19 percent of Americans say they take some sort of drug daily to help them relax. The rate of drug use varies widely by state, from 28 percent in West Virginia to 13.5 percent in Alaska. The findings come from an ongoing Gallup survey, conducted with health consultants Healthways, according to NBC News. The survey included calls to more than 176,000 adults nationwide. They were asked how often they use drugs or medications, including prescription drugs, which affect their mood and help them relax. Respondents were not asked about the types of drugs used. After West Virginia, the states with the highest daily drug use were Rhode Island (26 percent), Kentucky (24.5 percent), Alabama (24.2 percent), Louisiana (22.9 percent), South Carolina (22.8 percent), Mississippi, Missouri and Indiana (22 percent) and Oregon (21.9 percent). The states where the fewest people use daily drugs, after Alaska, are Wyoming (15.5 percent), California (15.8 percent), Illinois (16 percent), North Dakota (16.4 percent), New Jersey (16.5 percent), Colorado (16.7 percent), Texas (16.7 percent), Utah (16.8 percent) and Maryland (17.3 percent). People who take drugs daily to relax have an overall lower feeling of well-being, Gallup noted in a statement. "One possibility is that taking mood-altering drugs or medication nearly every day contributes to lower well-being," the organization noted. "But a more probable explanation is that Americans who already have lower well-being are more likely to use drugs or medication to relax or alter their mood, possibly to help cope with challenges related to their low purpose, social, financial, physical or community well-being."
Posted by Marianne Karg at 10:23 AM
Thursday, March 12, 2015
Senate Bill Would End Federal Prohibition on Medical Marijuana MARCH 11TH, 2015 A bill introduced Tuesday by three U.S. senators would end the federal prohibition on medical marijuana, The Washington Post reports.The bill was introduced by Cory Booker of New Jersey and Kirsten Gillibrand of New York, both Democrats, and Rand Paul of Kentucky, a Republican. The Compassionate Access, Research Expansion and Respect States (CARERS) Act, would reclassify marijuana from Schedule I to Schedule II under the Controlled Substances Act. Schedule I drugs, which include heroin, have no accepted medical use in the United States. Schedule II drugs have a legitimate medical use but also have a high potential for abuse. The bill would permit Veterans Affairs doctors to prescribe medical marijuana to veterans, and would make it easier for scientists to obtain marijuana for medical research. It would allow banks and credit unions to provide the same services to the marijuana industry as they do to other businesses, without the fear of federal prosecution or investigation, the article notes. Because marijuana is still illegal under federal law, banks have been reluctant to conduct business with marijuana-related companies. Banks have feared being accused of helping these businesses launder their money. The measure would not legalize medical marijuana in all 50 states, but would prevent federal law enforcement from prosecuting patients, doctors and caregivers in states that have their own medical marijuana programs. Currently 23 states plus the District of Columbia have legalized medical marijuana. An additional 12 states have approved use of marijuana strains with high levels of cannabidiol (CBD), which does not produce the high associated with the drug, and is used to treat epileptic seizures. The measure would remove specific strains of CBD oil from the federal definition of marijuana, to allow its use in treatment of intractable seizures. The bill’s fate in the Senate is unclear. /By JOIN TOGETHER STAFF
Posted by Marianne Karg at 12:57 PM
Friday, March 6, 2015
Heroin-Related Drug Deaths Highest Among Young, White Males in the Midwest MARCH 4TH, 2015 Heroin-related deaths are now most common among young, white male adults in the Midwest, according to a new report by the Centers for Disease Control and Prevention (CDC). Fifteen years ago, the death rate was highest among older black males in the West and Northeast. In 2013, there were 8,257 heroin-related deaths in the United States, up from 5,925 the previous year, CBS News reports. There were about 3,000 heroin-related deaths in 2010. The deaths have increased among both men and women, in all ages groups, and in whites, blacks and Hispanics, the article notes. In 2000, the highest heroin death rate was among blacks ages 45 to 64. By 2013, the highest rate was among whites ages 18 to 44. Drug overdoses are the number one cause of injury-related death in the United States, with 43,982 deaths occurring in 2013, according to the CDC. According to the Office of National Drug Control Policy, opioid use disorders often begin with a prescription or taking pills from a home medicine cabinet. Almost 68 percent of people who begin using prescription drugs non-medically for the first time get the drugs from a family member or friend. Many people who initially abused prescription painkillers shifted to heroin, which is cheaper and easier to obtain By: Join Together Staff
Posted by Marianne Karg at 1:59 PM
Thursday, February 19, 2015
“Therapeutic Workplaces” Aim to Help Employees Tackle Drug Addiction FEBRUARY 17TH, 2015 Researchers at Johns Hopkins University say workplaces designed to help employees who are addicted to drugs can help them tackle their addiction. These “therapeutic workplaces” have been shown in studies to increase abstinence from drugs and maintain abstinence over long periods. These workplaces require frequent drug tests, and give employees unlimited second chances, Scientific American reports. Employees who stay off drugs are given cash bonuses. Those who test positive are sent home, but can return the next day. If they test negative, they can work full-time for an hourly wage until their next drug test. Researchers initially were concerned that giving employees cash bonuses would tempt them to buy more drugs. Instead, workers who received the bonuses in addition to hourly wages are abstinent for longer than those who simply receive an hourly wage. Some studies of therapeutic workplaces included workers addicted to cocaine, while others included those addicted to opioids who were receiving medication-assisted treatments such as methadone or naltrexone. The studies found about 80 percent of employees in therapeutic workplaces remained abstinent and refrained from other addictive behaviors, compared with half of those who worked without cash bonuses, the article notes. Last year the federal Office of National Drug Control Policy honored Dr. Kenneth Silverman, who heads therapeutic workplace research at Johns Hopkins. The concept has not widely spread throughout the addiction community. Most businesses are not able to use the model because of the intense monitoring required. Dr. Silverman is working with the group American Substance Abuse Professionals to increase use of the technique. By: Join Together Staff
Posted by Marianne Karg at 11:39 AM
Thursday, January 29, 2015
Almost One-Third of Women of Childbearing Age Fill Prescriptions for Opioid Painkillers January 27th, 2015 Almost one-third of women of childbearing age had an opioid painkiller prescription filled each year from 2008 to 2012, according to a new government study. These drugs can increase the risk for birth defects, The New York Times reports. The study, by the Centers for Disease Control and Prevention (CDC), found 39 percent of women ages 15 to 44 on Medicaid, and 28 percent of women of the same age group with private insurance, filled an opioid prescription in a pharmacy each of those years. “These are dangerous drugs that are addictive, and we are substantially overusing them,” said CDC Director Dr. Thomas Frieden. He noted that women often do not know they are pregnant in the early weeks of a pregnancy, which is a crucial time for organ formation. If they take opioid painkillers, they could be “unknowingly exposing their unborn child,” he said. Opioid painkiller exposure can raise the risk for defects in a baby’s brain, spine, heart and abdominal wall, the article notes. Babies whose mothers take opioids during pregnancy are also at risk of neonatal abstinence syndrome. A baby with the syndrome experiences symptoms of withdrawal from medications or drugs taken by a mother during pregnancy. The researchers said it is not known why women on Medicaid had higher prescription rates than women with private insurance. “The higher opioid prescribing rates among Medicaid enrollees might be due to differences in the prescription medications covered under their health insurance plan, differences in use of health care services, or differences in the prevalence of underlying health conditions among Medicaid enrollees compared with persons covered by private health insurance,” the CDC noted in a news release. Oxycodone, hydrocodone and codeine were the most frequently prescribed opioids for women with either public or private insurance.
Posted by Marianne Karg at 11:06 AM
Thursday, January 22, 2015
Federal Judge to Rule on Whether Marijuana is Schedule I Drug /By JOIN TOGETHER STAFF JANUARY 15TH, 2015 A federal judge will rule later this year on whether marijuana should continue to be classified as a Schedule I drug, alongside LSD and heroin, according to the Associated Press. U.S. District Judge Kimberly J. Mueller agreed to consider marijuana’s drug classification under the 1970 Controlled Substances Act. She held a five-day fact-finding hearing in late 2014. Final arguments are scheduled for February. Her decision to hold the hearing was in response to a pretrial defense motion in a federal case against alleged marijuana growers, the article notes. Schedule I drugs are defined as drugs with no currently accepted medical use and a high potential for abuse. “Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence,” the Drug Enforcement Administration notes on its website. If Mueller ruled that marijuana is not a Schedule I drug, it would apply only to the defendants in the case. It would almost certainly be appealed, according to the article. If the U.S. 9th Circuit Court of Appeals ruled the law was unconstitutional, all the Western states would be affected. Lawyers for the defendants in the case say the federal marijuana law violates the Constitution’s guarantee of equal protection under the law. They argue the government enforces marijuana law unevenly by permitting marijuana to be distributed in states where it is legal, while cracking down in states where it is illegal. Zenia K. Gilg, a lawyer for the growers, said the scientific understanding and public acceptance of marijuana have greatly increased since courts last considered the federal classification.
Tuesday, January 6, 2015
DEA Cracks Down on Potent Marijuana Product Called “Wax” in California /By Join Together Staff Jan 6, 2015 The Drug Enforcement Administration (DEA) is cracking down in California on a potent marijuana product called “wax,” according to ABC News. Wax is legal—and popular—in Colorado. Wax is a distillation of marijuana said to be so potent that a single hit will keep a person high for more than a day, the article notes. A person making wax uses the flammable substance butane to strip out the THC, the chemical in marijuana that causes a high. “There is no weed out there that possesses the punching power that the wax does,” an anonymous undercover DEA informant told ABC News’ “Nightline.” “And it’s like smoking 20 joints of the best grade of weed that you have into one hit of the wax.” Gary Hill of the DEA’s San Diego office said, “We have seen people have an onset of psychosis and even brain damage from that exposure to that high concentration of THC. Our concern is that this is going to spread before we get it under control.” In Colorado, wax is legal for anyone over the age of 21. It is sold in recreational marijuana dispensaries. A three-day contest called the X-Cup, held in Denver, is designed to determine who can make the most potent batch of wax.
Posted by Marianne Karg at 10:10 AM
Friday, December 12, 2014
Nearly 60 Percent of American Adults Have Problem Holiday Drinking The December holiday season may mean much merriment, but according to this survey, 59 percent of American adults who attend holiday parties drink too much and engage in potentially serious and dangerous behavior. The online survey, conducted by Harris Poll and commissioned by Caron Treatment Centers, polled 2,000 American adults over the age of 18. Some of the most concerning statistics pertain to parents with children under the age of 18 living at home. Of parents age 21+ who attend and drink at parties, one in four (26 percent) admit to driving home from a party after drinking too much. One in five (21 percent) have blacked out and couldn’t remember anything after drinking too much at a party. “Alcohol is still one of the deadliest drugs in our society,” said Doug Tieman, Caron’s president and CEO. “Our culture has normalized substance abuse to the extent that many people don’t perceive significant consequences as cause for concern even though they can indicate serious problems. Many of the unintended victims, of course, are our children. We all need to be accountable for our behavior. But, if you are an alcoholic, it’s unlikely that you can change your behavior without significant help. You will need support to develop the skills and tools to lead a happy and productive life without alcohol.” In addition, 55 percent of adults who attend holiday parties have seen someone drive even though they appeared to be impaired and 32 percent admit they drove impaired themselves. Surprisingly, 40 percent of adults over the age of 65 who drink at parties admit to driving while impaired compared to just 21 percent of 21-34 year olds. Even though they are breaking the law, parents with children under the age of 18 still living at home, are still providing them with alcohol. • 48 percent said it’s acceptable for 18-20 year olds to have at least one drink at a family holiday party if they are not driving. • 12 percent said it is acceptable for an 18-20 year old to drink any amount at a family holiday party if they are not driving. “Serving alcohol to minors is not only illegal, but sends a permissive message and can lead to serious and even deadly consequences,” said Dr. Harris Stratyner, PhD, Regional Clinical Vice President of Caron Treatment Centers in New York. “It’s never safe for an underage person to drink, even when ‘supervised,’ as drinking puts them at risk for emotional, physical, and psychological problems. Drinking at a young age may also cause brain, liver, and growth problems, and make someone more likely to develop an addiction later in life.” The survey showed that many Americans have misconceptions about alcoholism. • 37 percent believe most alcoholics cannot hold down a full-time job. • 72 percent agree that most alcoholics drink every day. • 10 percent strongly agree with the statement: “Alcoholics could stop drinking if they wanted to, but they lack the willpower.” “With the popularity of social media and frequent use of mobile video/photo uploads, it’s important to recognize that any person’s actions while under the influence could be seen by a wide net of people,” said Dr. Stratyner. “The consequences can impact lives both personally and professionally.” If you believe that you, a friend or family member may have a problem with alcohol, the National Institute of Health has a tool that may be able to help. Go to http://rethinkingdrinking.niaaa.nih.gov/ to Rethink Your Drinking.
Posted by Marianne Karg at 10:02 AM
Thursday, November 6, 2014
Recreational Marijuana Legalized in Oregon and Alaska NOVEMBER 5TH, 2014 Oregon and Alaska voted to legalize recreational marijuana use on Tuesday. In Washington, D.C., residents voted to allow possession of marijuana, but not retail sales of the drug, Reuters reports. Marijuana remains illegal under federal law. Oregon and Alaska will follow Colorado and Washington state which legalized recreational use of marijuana in 2012. Preliminary results indicate 54 percent of Oregon voters supported the marijuana measure, which takes effect in July 2015. Retail marijuana stores could open in 2016. In Alaska, 52 percent of voters supported legal marijuana, according to preliminary results. Once the election is certified, a state commission would have nine months to come up with regulations. Stores would be likely to open in 2016. The Washington, D.C. measure could be halted by the U.S. Congress, which has constitutional oversight of the nation’s capital, the article notes. Under the measure, adults 21 and older could possess up to two ounces of marijuana and grow up to six plants. Voters in Florida defeated a constitutional amendment to allow medical marijuana. In Maine, proposals to legalize the possession of small amounts of recreational marijuana passed in South Portland and failed in Lewiston. Opponents of legalization in Oregon said they will advocate for stricter laws aimed at limiting access to marijuana by children. Kevin Sabet, co-founder of anti-legalization group Smart Approaches to Marijuana, said his group intends to build a broader coalition to counter pro-marijuana groups in 2016. “Tonight is going to inspire us to do better and to try harder and go after the donors we have to go after in order to level the playing field,” Sabet said. “The more people that hear about legalization, the more people are uncomfortable with it. For us it’s about getting our message out.”
Thursday, October 23, 2014
Study Finds Positive Drug Test from Secondhand Marijuana Smoke Unlikely OCTOBER 22ND, 2014 A new study finds it is unlikely that a person exposed to secondhand marijuana smoke will test positive for marijuana themselves. While it is possible that extreme marijuana smoke exposure could produce a positive urine test, this occurrence is likely to be rare and limited to the hours immediately after exposure, according to researchers from Johns Hopkins University. Six experienced marijuana users smoked marijuana with different concentrations of THC, the drug’s psychoactive ingredient, in a sealed chamber. Six non-smokers were seated next to the smokers. In two sessions, the participants were in a room with no ventilation, while in the third session they were in a ventilated room. The non-smokers’ urine was tested 13 times over the next 34 hours. Urine levels of THC surpassed typically detectable levels in only one participant, four to six hours after exposure. When the researchers used a more sensitive test, which is usually not used in workplace drug testing, they could detect lower THC levels, but only for 24 hours. Non-smokers in the ventilated room did not come close to meeting the threshold for a positive drug test, Newsweek reports. /By JOIN TOGETHER STAFF
Posted by Marianne Karg at 2:59 PM
Tuesday, September 23, 2014
Recreational Marijuana Sales Surpass Medical Cannabis in Colorado SEPTEMBER 11TH, 2014 Sales of recreational marijuana have surpassed sales of medical marijuana for the first time in Colorado, according to an analysis of state tax revenues. Whether recreational marijuana will become a profit center for the state remains in question, Time reports. The state’s recreational marijuana shops opened in January. The state tax on medical marijuana is 2.9 percent, compared with 10 percent for recreational marijuana sold in state stores. In July, the state received $838,711 from medical marijuana taxes, and $2.97 million from recreational marijuana taxes. Consumers bought an estimated $28.9 million worth of medical marijuana at dispensaries, and $29.7 million worth of recreational marijuana at state recreational marijuana stores. The July sales figures boost legalization proponents’ argument that recreational marijuana will be profitable for Colorado, the article notes. In July, an editorial in The Denver Post noted medical marijuana purchases easily outpaced retail marijuana sales. The editorial noted it is relatively easy to get certified to obtain medical marijuana, and that the number of people with certifications grew from 110,979 at the beginning of the year to 116,180 at the end of April. A portion of medical marijuana users “almost certainly belong” in the retail market, the editorial stated. “Medical marijuana privileges should be confined to genuine patients, particularly now that the retail option exists, and not to those merely seeking a break on price because the taxes are lower,” the newspaper wrote. In July, Dr. Larry Wolk, head of the Colorado Department of Public Health and Environment, told The Denver Post he was concerned there may not be much incentive for people to switch from medical marijuana to retail marijuana. /By JOIN TOGETHER STAFF
Posted by Marianne Karg at 2:12 PM
Thursday, September 11, 2014
DEA Will Allow Unused Narcotic Painkillers to be Returned to Pharmacies The Drug Enforcement Administration (DEA) announced Monday it will allow unused narcotic painkillers such as OxyContin to be returned to pharmacies. Until now, pharmacies were not allowed to accept unused opioid painkillers. The Controlled Substances Act required patients to dispose of the drugs themselves or give them to law enforcement during twice-yearly national “take-back” events. Consumers will also be permitted to mail unused prescription medications to an authorized collector, in packages that will be available at pharmacies and locations including senior centers and libraries, The New York Times reports. The new regulations are designed to curb the prescription drug abuse epidemic, the DEA said. “These new regulations will expand the public’s options to safely and responsibly dispose of unused or unwanted medications,” DEA Administrator Michele Leonhart said in a news release. “The new rules will allow for around-the-clock, simple solutions to this ongoing problem. Now everyone can easily play a part in reducing the availability of these potentially dangerous drugs.” The regulations will take effect in one month, the article notes. In addition to OxyContin, the rule will include stimulants such as Adderall and depressants such as Ativan. The program will be voluntary for pharmacies. The DEA will require locations accepting drugs to permanently destroy them, but will not specify how they do it. The “take-back” events removed 4.1 million pounds of prescription drugs from circulation in the past four years, according to the DEA. During that time, about 3.9 billion prescriptions were filled. “They only removed an infinitesimal fraction of the reservoir of unused drugs that are out there,” said Dr. Nathaniel Katz of Tufts University School of Medicine in Boston, who studies opioid abuse. “It’s like trying to eliminate malaria in Africa by killing a dozen mosquitoes.” Flushing drugs down the toilet, or throwing out prescriptions in the trash, are discouraged because they could harm the environment. /By Join Together Staff September 9th, 2014
Posted by Marianne Karg at 12:20 PM
Monday, September 8, 2014
Medical marijuana and workplace safety Amid a flurry of new laws, more questions than answers exist Tom MusickAugust 24, 2014 Key points ■State laws vary, but employers still have the right to enforce drug-free workplace policies and dismiss workers if they can prove impairment on the job, experts say. ■The issue remains in flux as legal battles play out in state courts across the country. ■Research is limited on the subject, but two medical organizations recently formed a task force to study workplace health and safety issues associated with marijuana. Julie Carter is well aware of the burgeoning movement to legalize medical marijuana. It’s debated at jobsites. It’s splashed across headlines. It’s discussed among safety professionals. And no matter your stance on the issue, one thing is certain: It’s not going away anytime soon. “I think it’s going to be a hot-button issue for some time yet because things are changing so rapidly,” said Carter, director of environmental, health and safety at Roy Anderson Corp., a Gulfport, MS-based construction company. “As a corporation, we are maintaining that we have the right to a drug-free workplace. Those are our policies, period.” Yet when it comes to recent medical marijuana laws and what they might mean for workplace safety, the predominant punctuation is a question mark. The language of each law varies, leaving all parties involved having to navigate a legal maze when it comes to employers’ and workers’ rights. As of press time, 23 states and the District of Columbia had passed laws allowing the use of medical marijuana, and two of those states – Colorado and Washington – had passed laws permitting the recreational use of marijuana. (See map.) All of those laws stand in contrast to federal law, which prohibits marijuana as a Schedule I controlled substance in the same category as LSD, heroin and ecstasy. The federal government has said it will not prosecute people who abide by their state’s marijuana laws. As to whether employers can ban its use by workers – including those with prescriptions to use medical marijuana outside of the workplace for chronic diseases and conditions such as cancer, glaucoma, multiple sclerosis and Crohn’s disease – the answer depends on each state and its courts. In some states, including Washington, Oregon and Michigan, judges have ruled on the side of employers. In other states, including Minnesota, Arizona and Delaware, lawmakers have added specific protections for workers with medical marijuana prescriptions, shielding them from adverse action by employers based solely on a positive test result. “There are a lot of layers to it,” said Vance Knapp, a lawyer who represents employers in Colorado and Arizona for Denver-based Sherman & Howard LLC. “What we’re seeing is sort of a hodgepodge of rules and regulations from state to state to state.” Safety implications Marijuana is a mind-altering drug that contains more than 400 chemicals, according to the Drug Enforcement Administration. One of those chemicals, THC, is believed to be the main cause of psychoactive effects as it travels from the bloodstream to the brain. For a crane operator, pipe fitter, welder, truck driver or anyone else in a safety-sensitive position, the drug can pose dangers. The short-term effects of marijuana include distorted perception; loss of coordination; and problems with memory, learning and problem-solving, according to DEA. Workers should treat medical marijuana the same as other prescription drugs such as Vicodin or Percocet, which can impair mental and physical abilities and affect worker safety, said Rosalie Liccardo Pacula, a senior economist with Santa Monica, CA-based nonprofit research institute RAND Corp. Workers also should know the rules of their state and their employer, particularly if they are subject to Department of Transportation regulations or if their employer has federal contracts – both of which can supersede protections in state laws. Other variables exist, such as a wide range in potency levels of THC in different types of marijuana. Someone who ingests marijuana that has a higher THC content may become more impaired and, in turn, less safe. “We’re not talking about a single substance when we talk about marijuana,” said Pacula, who serves as co-director of the RAND Drug Policy Research Center. “It’s the equivalent of saying ‘alcohol’ and encompassing hard liquor with low-alcohol-content stuff. We need our laws and policies to be more mindful of that.” Meanwhile, many safety professionals have become more diligent about observing employees during stretch-and-flex drills, lunch breaks and other encounters. “In some of the states where medical marijuana is legal, we have been increasing our awareness and making sure that we look at our employees,” Carter said. “Get a visual on them. [Be aware] if they seem not on their game, if they seem distracted – for any reason, but especially for that. We have this saying. We call it, ‘Eyes on hands, mind on task.’ When you’re stoned, you’ve got none of that going on.” Employers’ rights versus workers’ rights If an employer can prove a worker is impaired on the job, then that employer can take action regardless of the residing state. But what if a worker shows no impairment but tests positive for marijuana? Does the employer have the right to fire that worker as part of its drug-free workplace policy? Knapp’s short answer consists of two words: “Yes, but …” His long answer covers a slew of recent court cases, most notably Colorado’s Coats v. Dish Network. The plaintiff in that case, Brandon Coats, is a quadriplegic licensed to take medical marijuana. After Coats failed a drug test, Dish Network fired him from his job as a customer service representative. Coats sued the company, but the state’s Court of Appeals sided with Dish Network. At press time, the case was pending in the Colorado Supreme Court. “I’ve been advising my clients that you can have a zero-tolerance drug policy in your workplace, but there is that risk that there’s going to be litigation,” Knapp said. “The issue for employers, especially employers who are engaged in safety-sensitive activities, is that they have to be concerned about, ‘Can I still discipline an employee that has trace amounts of THC in their bloodstream?’ … When it comes down to the particulars of what you can or cannot do under your particular state law, that’s when you really need to contact your employment counselor.” Employers have been doing exactly that in Minnesota, which in May became the 22nd state to legalize medical marijuana. On the surface, the language in Minnesota’s law might make it the most employee-favorable law in the country, said Dale Deitchler, a Minneapolis-based attorney who specializes in labor law with Littler Mendelson. “In states where employment is not addressed, employers have the upper hand,” Deitchler said. “In states where employment is addressed, there’s no clear-cut winner coming out of this, and companies are going to have to understand that if there’s a legal challenge, they’re going to have to make new law.” Searching for answers As more states legalize some form of marijuana use, researchers and medical professionals are doing their best to keep pace by studying the drug’s effects. Earlier this year, the American College of Occupational and Environmental Medicine and the American Association of Occupational Health Nurses announced plans to create a collaborative task force to study workplace health and safety issues associated with the use of marijuana and other drugs. Dr. Kathryn Mueller, president of ACOEM, said the task force’s goal is to avoid politicized rhetoric and analyze scientific information to help physicians and employers. “For safety-sensitive jobs, I think that people are not going to allow marijuana to be used on the job because it’s going to be a problem, most likely,” Mueller said. “The question remains, if you are using medical marijuana in some way, does that preclude you from all jobs that are available?” The answer, as with almost everything else regarding medical marijuana, is up for debate. “I suspect this is something that is going to get resolved by lawyers in court, and it will take a little while,” Pacula said. “But right now, there appears to be a lot of variation in how states are addressing it because they haven’t really been thinking about it. It’s all very new.” Tom Musick Associate Editor
Posted by Marianne Karg at 10:32 AM
Wednesday, September 3, 2014
Employers’ new challenge: drug testing employees for synthetics Companies, testing facilities need to cope with rise in synthetic drug use By Trish Mehaffey, The Gazette Published: August 31 2014 | 12:01 am in News, CEDAR RAPIDS — Manufacturers of synthetic drugs such as K-2 stay one step ahead of the law by changing the chemical make up when one substance is banned. That isn’t only a problem for law enforcement but also for employers as they strive to create safe workplace environments. Employers are now faced with the dilemma of paying an added expense to test employees for synthetic cannabinoids and cathinones, which differ from the regular drug tests. However, those tests may not be reliable because when the products are altered to skirt the law, new drug testing panels have to be developed to detect the recently created products. Iowa Division of Narcotics Enforcement Special Agent Dan Stepleton said the trend of synthetic cannabinoids and cathinones isn’t going away. “We have the convenience shops and head shops selling under control, but they are just getting smarter about it,” Stepleton said last week. “They don’t have it out in the open, and the regular customers know to ask for it.” Stepleton said the manufacturers change the man-made chemicals sprayed on the materials to produce that “high” practically every week. “Outlaw one and there 15 new ones,” he said. There were two recent convictions of distributors and three more are pending trials in this district’s federal court. In the wake of one death and five overdoses attributed to synthetics, the city of Cedar Rapids just amended an ordinance to fine and criminally charge anyone selling or buying products. Eastern Iowa businesses that require drugs screens as part of the pre-employment process were asked if they were adding additional testing for synthetics, but many declined to comment and wouldn’t discuss their policies. However, Dennis LaGrange, a Mercy Medical Center counselor and licensed social worker, said about 50 percent of company supervisors he works with are aware of K-2 — a synthetic cannabis — but others had no knowledge of these illicit drugs. He provides drug and alcohol education for businesses, along with helping them set up their drug-free workplace policies. In the past year, LaGrange has gone to 30 local companies to provide on-site workplace drug education training and offered about eight trainings at Mercy for smaller companies. Dale Woolery, associate director of the Governor’s Office of Drug Control and Policy in Des Moines, said employers and human resource managers have been asking for information or education on synthetics for the last few years. “It’s challenging for the workplace to keep up with the laws and the companies making the testing products, but a few years ago we couldn’t even detect synthetics,” Woolery said. “Technology is catching up.” Woolery said the total number of synthetic drug compounds listed as Schedule I controlled substances in Iowa now stands at 64, plus five classes of synthetic cannabinoids. QPS Employment Group, a staffing agency with 12 branches across the Iowa, including Cedar Rapids and Iowa City, places employees in many manufacturing and other companies. Its regional vice president, Jim Roy, has discovered many aren’t aware the standard 10-panel drug tests don’t detect synthetics. “When they find out there’s more cost to add synthetics, not many are willing to pay the cost,” Roy said. Gary Bucher, owner of ARCpoint Labs in Des Moines, said the standard 10-panel tests range from $50 to $60 per person. To add the two synthetic tests, it would be twice that amount. He has interest from employees wanting to test for synthetics, but that cost deters them. His labs have done testing for parents who request it and for treatment agencies, though. The standard 10-panel tests only detect marijuana, cocaine, amphetamines (methamphetamine), opiates (heroin), phencyclidine (PCP), barbiturates, methadone, propoxyphene, methaqualone (quaaludes) and benzodiazepine (Xanex), noted Dr. Shirley Pospisil with St. Luke’s Work Well Clinic. Pospisil said the clinic has tested 59 employees for K-2 this year from a company participating in Work Well and all came back negative. She said she wasn’t that familiar with synthetic drugs, except from reading the research, but they can cause irreparable damage and even death in some cases reported here and across the country. According to a DEA fact sheet, synthetic cannabinoids can cause severe agitation and anxiety, elevated blood pressure, tremors and seizures, hallucinations and suicidal and other harmful thoughts or actions. Synthetic cathinone — similar to amphetamines — use is associated with increased heart rate and blood pressure, chest pain, extreme paranoia, hallucinations and violent behavior. Local labs such as Weland in Cedar Rapids hasn’t tested synthetics for employers, only drug treatment programs, and C.J. Cooper and Associates in Hiawatha only tests synthetics for law enforcement and the Iowa Department of Corrections. Dr. Robert Hatcher with Iowa City Drug and Alcohol Testing said he hadn’t tested for employers but he’s had some inquiries from parents about testing their teens — but no one has followed through. But the reliability of the tests is an issue, said Justin Grodnitzky, a criminalist with the Iowa Division of Criminal Investigation. The testing panels could be six months behind what authorities are seeing on the street. Another challenge is that the synthetic drugs process through the system faster, some within two hours — unlike marijuana and some other drugs. “Employers have to make informed decisions when it comes to testing,” said Barry Sample, director of Science and Technology for Employers Solutions of Quest Diagnostics in Madison, N.J. His company provides drug testing education to employers across the country and, he said, they all are dealing with those same issues. He has been providing education about synthetics since 2010. “I think most employers are aware of synthetics and recognize the threat,” he added. He doesn’t think it’s necessarily practical for employers to test for synthetics as part of the pre-employment process. Sample recommends they should test if there is “reasonable suspicion.” For more information on Synthetics or Reasonable suspicion testing & training contact Mobile Medical Corporation 888-662-8358 ext. 201
Monday, August 25, 2014
ER Visits Involving Sleep Drug Overmedication Almost Doubles /By Join Together Staff August 12th, 2014 The number of emergency department visits involving the sleep drug zolpidem (the active ingredient in Ambien) almost doubled over four years, according to a new government report. Zolpidem-related ER visits rose from 21,824 in 2005-2006, to 42,274 in 2009-2010, the Substance Abuse and Mental Health Services Administration (SAMHSA) found. In 2010, females accounted for two-thirds of zolpidem-related ER visits involving overmedication. The largest number of visits related to overmedication with the drug involved patients ages 45 to 54. More than half of zolpidem-related ER visits also involved other prescription drugs, including other anti-anxiety and insomnia medications and narcotic pain relievers. In addition, 14 percent of visits involved alcohol combined with zolpidem. Almost half of ER visits related to zolpidem overmedication resulted in either a hospital admission or a transfer to another medical facility. About one-quarter of these more serious cases involved admission to a critical or intensive care unit, the report noted. CBS News reports that hospital ER visits involving drug-related suicide attempts in people ages 45 to 64 doubled from 2005 to 2011. In 2010 there were almost 5 million drug-related visits to emergency departments throughout the country, according to SAMHSA. In 2013, the Food and Drug Administration (FDA) required manufacturers of drugs containing zolpidem to reduce the recommended dose by half for females, in response to increasing numbers of reports of adverse reactions. The FDA suggested drug makers also reduce the recommended dose for men. Zolpidem’s side effects can include daytime drowsiness, hallucinations, dizziness, agitation and sleepwalking. When combined with other substances, the sedative effects of zolpidem can be dangerously enhanced, SAMHSA noted in a news release.
Posted by Marianne Karg at 11:45 AM
Tuesday, July 29, 2014
Workplace Drug Testing — Helping Stop Accidents Before They Happen Posted Jul 29, 2014 Many people who have made it to the final stages of the job application process are familiar with pre-employment drug screening. Post-accident, random, return to duty, and reasonable suspicion are also reasons why an organization might drug test its employees. Why all the testing? To put it plainly, drugs and jobs just don’t mix. The National Council on Alcoholism and Drug Dependence, Inc. (NCADD) lists some job performance issues no employer wants to see at their sites: • Inconsistent work quality • Poor concentration and lack of focus • Lowered productivity or erratic work patterns • Increased absenteeism or on the job “presenteeism” • Unexplained disappearances from the jobsite • Carelessness, mistakes or errors in judgment • Needless risk taking • Disregard for safety for self and others- on the job and off the job accidents • Extended lunch periods and early departures Now, you can imagine that bullet point about “disregard for safety” struck a nerve. As safety professionals, you do your best to create a workplace safety culture that gets everyone home safe after their shift. You try to control potential dangers and make sure everyone knows what they need to know to safely perform all their job duties. Adding impaired workers into the mix only makes matters so much more difficult for employers, co-workers, and the abusers themselves. A workplace testing program, and employees who understand the rationale behind it, can help alleviate many of these concerns. NCAAD provides a downloadable fact sheet filled with stats that make the case for workplace testing: • Up to 40% of industrial fatalities and 47% of industrial injuries can be linked to alcohol consumption and alcoholism. • 21% of workers reported being injured or put in danger, having to re-do work or to cover for a co¬worker, or needing to work harder or longer due to others' drinking. • Absenteeism among alcoholics or problem drinkers is 3.8 to 8.3 times greater than normal and up to 16 times greater among all employees with alcohol and other drug-related problems. Drug-using employees take three times as many sick benefits as other workers. They are five times more likely to file a worker's compensation claim. • Shortfalls in productivity and employment among individuals with alcohol or other drug-related problems cost the American economy $80.9 billion in 1992, of which $66.7 billion is attributed to alcohol and $14.2 billion to other drugs. A 2011 poll by the Society for Human Resource Management (SHRM) in collaboration with and commissioned by the Drug & Alcohol Testing Industry Association (DATIA), offers these findings for consideration as well: • A fifth of organizations (19 percent) reported seeing an improvement in productivity. • Four percent of employers said they had high absenteeism rates (more than 15 percent) after implementing drug testing programs compared to 9 percent before beginning programs, a decrease of more than 50 percent. • Six percent of organizations saw workers’ compensation incidence rates of more than 6 percent after implementing programs compared to 14 percent before starting drug testing programs, a decrease of more than 50 percent. • For employers with drug testing programs, 16 percent reported a decrease in employee turnover rates, while 8 percent reported an increase, after the implementation of a drug testing program. Mobile Medical Corporation provides testing and training that will educate the employer and employee on: • When testing needs to occur, including pre-employment, random, post accident, reasonable suspicion, return to duty, and follow-up testing • Why testing for alcohol and other drugs is required for transportation workers • Importance of maintaining a drug- and alcohol-free workplace Call Today: 888-662-8358 for more information
Posted by Marianne Karg at 3:38 PM
Thursday, July 17, 2014
One in five workers drunk on the job by Janie Smith | 04 Jul 2014 Workplace drug testing gets a fair amount of media coverage, but there is a potentially far larger issue that employers need to be aware of – alcohol. A survey conducted by the Australian Drug Foundation found that nearly one in five employees had performed work duties while drunk or tipsy. A similar number admitted to pulling a sickie due to the effects of alcohol, while about 40% said they’d gone to work while still feeling the effects of their drinking. According to the foundation, alcohol and other drugs cost Australian businesses $6 billion per year in lost productivity and absenteeism, with alcohol use contributing to five per cent of workplace deaths and 11 per cent of accidents. Phillip Collins, the foundation’s head of workplace services, told HC that employers needed to realise that drinking was not an “at-home issue”, even though the majority of alcohol is consumed outside of office hours. “People don’t really understand the knock-on effect of alcohol. They think you can have a party at night and come to work the next day and be fully functional. But the truth is, alcohol takes a lot longer to get out of the system than people recognise. It impacts your performance.” Collins said studies showed that a blood alcohol concentration of 0.09, nearly double the legal driving limit of 0.05, caused a massive drop-off in cognitive skills and huge variations with regards to motor skills. “If you’re in a factory doing some assembly, there are big error rates that can occur. Or if you’re a manager doing cognitive work, you can make poor judgements. You might not feel over the limit or under the weather, but cognitively and motor skills-wise, you can actually be quite impacted.” He said organisations needed to have a robust alcohol and drug policy that wasn’t just a behavioural statement, but was ingrained in the business. It needed to cover things like what employees did in a social setting, how they interacted with clients and what the drinking cut-off rate was. “Are you going for zero tolerance, are you going for a three-strike policy? There are a lot of things in the policy that need to be addressed, not simply a throw-away line to say, ‘Hey, we’re banning alcohol’. “In certain settings, that’s actually a very difficult thing to do. If you’re in a sales environment, you may be called upon to entertain a client or to have a meeting over lunch or dinner and if you have a zero tolerance policy on alcohol, that’s not workable.” Collins said organisations had to look at the reality of their business to make sure its drug and alcohol policy was a good cultural fit and it was able to continue to do business while providing a safe working environment. Communicating the policy was also key, he said. “A lot of policies are created and put on the shelf where they collect dust and nobody actually knows about them until something goes wrong.” Reiterating the policy was particularly important around high-risk times like Christmas and the “silly season” period, when parties were more common. Legally speaking, dealing with employees who came to work under the influence was up to the organisation, said Collins. “Apart from them not being able to break any laws – so if they’re over the limit of 0.05 they can’t drive – there’s no legislation that tells an organisation, ‘This is what you have to do’. It’s really up to the organisation to set those boundaries.” Managers also needed to be educated on how to identify that someone is intoxicated. “You don’t want to identify someone who might look intoxicated but is actually on prescription medication. Organisations have to become a bit smarter about what they do and there hasn’t been any real skill set that’s been put into the HR space that allows everyone to be upskilled.” Are your employees up to speed with the company’s drug and alcohol policy?
Posted by Marianne Karg at 4:58 PM
Tuesday, July 15, 2014
Women and PPE: Finding the right fit Employers need to keep women in mind when purchasing PPE Thomas J. Bukowski June 22, 2014 ■PPE such as gloves, fall-arrest harnesses and safety boots that are designed for men may not fit women because of differences in average body dimensions. ■Some experts insist that employers should provide separate PPE for men and women rather than unisex PPE, which may not fit a woman properly. ■Employers should seek out distributors that offer a full range of PPE for both men and women, stakeholders say. Personal protective equipment is one of the last lines of defense for workers against injuries. However, in certain industries such as construction, women are less fortunate than men when it comes to finding gear that fits properly. “I am a woman under 5 feet [tall] and I can tell you, there isn’t much PPE that fits me properly.” – Leah Curran, an employee with New Castle, DE-based Tri-Supply & Equipment “I have had many difficulties in providing my female workers with properly fitting PPE. Anywhere from women’s fire-retardant clothing to gloves appropriate for the job.” – Jeannette Fletter, environmental, health and safety manager for Belectric, a Newark, CA-based renewable energy sources provider “When I first started and needed to wear a hard hat, I’d have to try three or four different models before finding one I was comfortable with.” – Jennifer Grande, safety coordinator with Collins, NY-based Gernatt Asphalt Products Inc. OSHA cites the lack of a full range of PPE sizes and types at the retail, wholesale and distributor levels – as well as employers’ limited knowledge of PPE designed for women – as some of the reasons for the difficulty women encounter with PPE. Another issue may be the low number of women in industries requiring PPE. According to OSHA, in 2010 about 9 percent of workers – or 818,000 – in the construction industry were women. Of those, only about 200,000 worked as laborers or in other positions at construction sites. “Since the industry is majority employed by men, the majority of PPE is going to fit men, but that doesn’t mean PPE shouldn’t be made to fit women,” said Curran, who also is the incoming safety chair for the Fort Worth, TX-based National Association of Women in Construction. “Women may face safety risks because PPE and clothing are often designed for the average-sized [man].” Ill-fitting equipment PPE cannot protect a worker from hazards if it does not fit. Equipment designed for men may not fit women properly due to differences in body size, height and composition, said Hongwei Hsiao, chief of the Protective Technology Branch with NIOSH’s Division of Safety Research. “Women are not just [the] ‘small size’ of men; their body configurations … are different from those of men,” Hsiao said. Grande pointed to gloves and hard hats as examples of how poor fit can affect safety. “If gloves don’t fit right – if they are too big – they’re clumsy, and you may not be able to do your job as well,” she said. “If your hard hat falls off every time you look up, that’s not a good thing either – you may need to use one hand to hold it on.” According to Ziqing Zhuang, the respiratory protection research team leader of the Technology Research Branch at the NIOSH National Personal Protective Technology Laboratory, women may have a hard time finding protective clothing, fall-arrest harnesses and gloves that are not too large. Safety boots may be one of the most difficult pieces of PPE for female workers to find, Zhuang said, and he disagrees with a common notion that women should simply wear a man’s boot that is “two sizes smaller.” According to a 2006 publication from the Industrial Accident Prevention Association and the Ontario Women’s Directorate, a typical woman’s foot is both shorter and narrower than a typical man’s foot, so a smaller boot may be the right length but not the right width. PPE tips for women A publication developed by the Industrial Accident Prevention Association and the Ontario Women’s Directorate in 2006 offers tips for women workers looking for personal protective equipment that fits. •Earplugs – Disposable, foam earplugs are more likely to fit women, who typically have smaller ear canals. •Hard hats – Adding a chin strap can help hard hats or caps fit better and not fall off. •Safety goggles – Beware of goggles that state “one size fits all” – some may be too large for a woman’s face and could allow objects, fluids or other hazardous materials to enter through gaps in the seals. •Protective clothing – Taking a man’s garment and modifying it to fit a woman, such as rolling up sleeves or pant legs, can be dangerous because the excess material can become caught in machinery. •Safety gloves – Ensure all exposed skin is covered; the gloves allow for a safe grip so tools will not easily slip out of the hands; and the finger length, width and palm circumference of the gloves match those of the hands.
Posted by Marianne Karg at 10:41 AM
Thursday, June 26, 2014
Marijuana Use on the Rise in U.S. but Decreasing Globally: U.N. Report /By JOIN TOGETHER STAFF JUNE 26TH, 2014 Marijuana use is increasing in the United States as Americans change their attitude about the drug’s risks, according to a new report by the U.N. Office on Drugs and Crime (UNODC). Globally, marijuana use seems to be decreasing. The number of Americans ages 12 or older who used marijuana at least once in the previous year increased to 12.1 percent in 2012, from 10.3 percent in 2008, Reuters reports. More Americans are seeking help for marijuana-related disorders. It is too early to understand the impact of the legalization of recreational marijuana in Washington state and Colorado, the report noted. “For youth and young adults, more permissive cannabis regulations correlate with decreases in the perceived risk of use, and lowered risk perception has been found to predict increases in use,” the UNODC wrote. The report also noted there has been a surge in opium production in Afghanistan, and a fall in the global availability in cocaine. Worldwide output of heroin increased last year. Overall, drug use prevalence is stable around the world, the report concluded. About 5 percent of the world’s population ages 15 to 64 used an illicit drug in 2012. “There remain serious gaps in service provision. In recent years only one in six drug users globally has had access to or received drug dependence treatment services each year,” Yury Fedotov, Executive Director of UNODC, said in a news release. He added that about 200,000 drug-related deaths occurred in 2012.
Posted by Marianne Karg at 12:43 PM
Tuesday, June 17, 2014
Harvard Scientists Studied the Brains of Pot Smokers, and the Results Don't Look Good By Eileen Shim April 16, 2014 Harvard Scientists Studied the Brains of Pot Smokers, and the Results Don't Look Good Image Credit: AP The news: Every day, the push toward national legalization of marijuana seems more and more inevitable. As more and more politicians and noted individuals come out in favor of legalizing or at least decriminalizing different amounts of pot, the mainstream acceptance of the recreational use of the drug seems like a bygone conclusion. But before we can talk about legalization, have we fully understood the health effects of marijuana? According to a new study published in the Journal of Neuroscience, researchers from Harvard and Northwestern studied the brains of 18- to 25-year-olds, half of whom smoked pot recreationally and half of whom didn't. What they found was rather shocking: Even those who only smoked few times a week had significant brain abnormalities in the areas that control emotion and motivation. "There is this general perspective out there that using marijuana recreationally is not a problem — that it is a safe drug," said Anne Blood, a co-author of the study. "We are seeing that this is not the case." The science: Similar studies have found a correlation between heavy pot use and brain abnormalities, but this is the first study that has found the same link with recreational users. The 20 people in the "marijuana group" of the study smoked four times a week on average; seven only smoked once a week. Those in the control group did not smoke at all. "We looked specifically at people who have no adverse impacts from marijuana — no problems with work, school, the law, relationships, no addiction issues," said Hans Breiter, another co-author of the study. Using three different neuroimaging techniques, researchers then looked at the nucleus accumbens and the amygdala of the participants. These areas are responsible for gauging the benefit or loss of doing certain things, and providing feelings of reward for pleasurable activities such as food, sex and social interactions. "This is a part of the brain that you absolutely never ever want to touch," said Breiter. "I don't want to say that these are magical parts of the brain — they are all important. But these are fundamental in terms of what people find pleasurable in the world and assessing that against the bad things." Shockingly, every single person in the marijuana group, including those who only smoked once a week, had noticeable abnormalities, with the nucleus accumbens and the amygdala showing changes in density, volume and shape. Those who smoked more had more significant variations. What will happen next? The study's co-authors admit that their sample size was small. Their plan now is to conduct a bigger study that not only looks at the brain abnormalities, but also relates them to functional outcomes. That would be a major and important step in this science because, as of now, the research indicates that marijuana use may cause alterations to the brain, but it's unclear what that might actually mean for users and their brains. But for now, they are standing behind their findings. "People think a little marijuana shouldn't cause a problem if someone is doing OK with work or school," said Breiter. "Our data directly says this is not so
Posted by Marianne Karg at 11:36 AM
Friday, June 13, 2014
Research on Marijuana’s Role in Car Crashes Expands as Drug Availability Grows /By Join Together Staff June 10th, 2014/ As marijuana becomes more readily available, a growing number of researchers are studying the possible link between marijuana and fatal car crashes, USA Today reports. A study published earlier this year by Columbia University researchers found marijuana contributed to 12 percent of traffic deaths in 2010. The study of almost 24,000 fatal car accidents found marijuana was linked to three times as many traffic deaths compared with a decade earlier. According to a 2010 survey by the National Highway Traffic Safety Administration (NHTSA), one in eight high school seniors said they drove after smoking marijuana. Almost one-quarter of drivers killed in drug-related crashes were younger than 25, the article notes. In addition, almost half of fatally injured drivers who tested positive for marijuana were under age 25. The National Institute on Drug Abuse (NIDA) and NHTSA have been conducting a three-year study to determine how inhaled marijuana impacts driving performance. NIDA notes on its website, “Considerable evidence from both real and simulated driving studies indicates that marijuana can negatively affect a driver’s attentiveness, perception of time and speed, and ability to draw on information obtained from past experiences. Research shows that impairment increases significantly when marijuana use is combined with alcohol.” NIDA notes it is difficult to measure the exact contribution of drug intoxication to driving accidents, because blood tests for drugs other than alcohol are inconsistently performed, and many drivers who cause accidents are found to have both drugs and alcohol in their system, making it hard to determine which substance had the greater effect. Lawmakers in Washington state, where recreational marijuana use is now legal, are trying to determine how police officers can identify drivers impaired by marijuana use. There is no consensus on what blood level of THC, the active ingredient in marijuana, impairs driving, the newspaper notes. Breathalyzers cannot be used for marijuana.
Posted by Marianne Karg at 11:56 AM
Thursday, May 15, 2014
Painkiller Overdose Deaths Have Tripled: Government Report By Join Together Staff | May 15, 2014 | Overdose deaths from prescription narcotics tripled from 2009-2010, compared with a decade earlier, according to a new government report. Almost half of Americans are taking one or more prescription medications, the report found. An estimated 10.5 percent are prescribed painkillers. The Centers for Disease Control and Prevention (CDC) report found among people ages 15 and older, painkiller use led to 6.6 deaths for every 100,000 people in 2009-2010, compared with 1.9 deaths per 100,000 in 1999-2000. According to the CDC, 17.7 percent of Americans take prescription medication for cardiovascular disease; 10.7 percent take cholesterol-lowering medication; 10.6 percent take antidepressants; and 9 percent take anti-acid reflux drugs, Time reports. The report found a large jump in the percentage of Americans taking prescription medication, according to HealthDay. From 2007 to 2010, about 48 percent of people said they were taking a prescription drug, up from 39 percent from 1988 to 1994. About 90 percent of adults ages 64 and older took prescription medication in the past month, while 25 percent of children did so. About 10 percent of Americans said they had taken five or more prescription drugs in the previous month. The rising use of medications has unintended consequences, including prescription drug abuse and antibiotic resistance. “Isn’t that the case with all forms of medical technology?” said Julia Holmes, Chief of the Analytic Studies Branch at the CDC’s National Center for Health Statistics. “It results in great benefit to people who are ill and disabled, but there’s always the potential for inappropriate use.”
Posted by Marianne Karg at 11:54 AM
Thursday, May 8, 2014
DEA Arrests at Least 150 People in Synthetic Drug Operation in 29 States By Join Together Staff | May 8, 2014 | The Drug Enforcement Administration (DEA) announced Wednesday it conducted a major crackdown on synthetic drugs that involved the arrest of at least 150 people in 29 states, and the seizure of more than $20 million in products and cash. Hundreds of thousands of packets of synthetic drugs were seized. The operation comes a week after more than 100 people in Texas became ill from synthetic marijuana, the Los Angeles Times reports. “There’s a cluster of people with severe anxiety, some with seizures, that could be because of synthetic cannaboids,” Dr. Miguel Fernandez, Director of South Texas Poison Center, told the newspaper. “I would caution people not to use them because they are not like typical marijuana.” Law enforcement officials and prosecutors have found it difficult to win convictions against makers of synthetic drugs, who are constantly changing the chemistry of the products to stay one step ahead of the law. In order to convict a synthetic drug maker, officials must prove the person sold the drug, and that the drug was substantially similar to a specifically banned substance. All a drug maker has to do is make small chemical changes to the products so they are not considered “analogues,” or chemical compounds that are similar to banned drugs. Last year, the DEA and authorities in three other countries announced the arrests of dozens of people involved in trafficking designer drugs such as bath salts and synthetic marijuana. In the United States, the enforcement operations took place in 49 cities, and targeted retailers, wholesalers and manufacturers. The operations included more than 150 arrest warrants and almost 375 search warrants. In 2013, the Substance Abuse and Mental Health Services Administration reported 29,000 emergency department visits nationwide in 2011 resulting from use of synthetic marijuana, up from 11,000 in 2010.
Posted by Marianne Karg at 11:37 AM
Monday, May 5, 2014
Two States to Consider Banning Powdered Alcohol By Join Together Staff | May 1, 2014 | Legislators in Minnesota and Vermont have introduced measures that would ban powdered alcohol, The Washington Post reports. The federal Alcohol and Tobacco Tax and Trade Bureau approved labels for a powdered alcohol product called “Palcohol,” but earlier this month said the approval was a mistake. Lipsmark, the company that makes Palcohol, has resubmitted an application, the article notes. Lipsmark says it plans to offer powdered alcohol in six varieties, including rum, vodka, Cosmopolitan, Mojito, Powderita and Lemon Drop. According to the company, a package of Palcohol weighs about an ounce and can fit into a pocket. It warns people not to snort the powder. Minnesota state Representative Joe Atkins this week introduced a bill that would ban powdered alcohol sales in his state. A similar bill is being considered in Vermont. Some health experts are afraid the product could be easily misused or abused. “Virtually every possible use for powdered alcohol is nefarious, not to mention potentially dangerous,” Atkins said in a news release. “The different flavorings make it appealing to children and students who could easily sneak packets into school. This powder could also be inhaled or snorted, bringing a whole new world of problems into play. With how quickly this is moving, we shouldn’t wait until next session to deal with this issue. We need to move quickly to protect public health.” Vermont state Senator Kevin Mullin, who introduced the measure to ban powdered alcohol in his state, told VPR News, “You can’t buy a bottle of gin at the liquor store if you’re 16. But there’s nothing that I can see in Vermont statute that would prohibit you from buying powdered alcohol, if it was available. So think about kids walking around with packets of powdered alcohol in their pocket – hard to detect.”
Posted by Marianne Karg at 3:10 PM
Wednesday, April 23, 2014
Countering the Myths About Methadone By Edwin A. Salsitz, MD | August 6, 2013 | Filed in Addiction, Healthcare, Prescription Drugs & Treatment Methadone maintenance has been used in the United States for approximately 50 years as an effective treatment for opioid addiction. Yet many myths about its use persist, discouraging patients from using methadone, and leading family members to pressure patients using the treatment to stop. Dr. Vincent Dole of Rockefeller University in New York, who pioneered the use of methadone as an opioid addiction treatment, found his patients no longer craved heroin. They were able to return to work and school, and participate in family life and community affairs. As methadone’s use grew, the federal government decided it should only be dispensed in licensed treatment programs, which would provide a whole range of services such as counseling, vocational help and medical and psychiatric treatment. This creation of the clinic system developed into a double-edged sword. On the one hand, it was advantageous to have many services available in the methadone clinic, but very stringent regulations came along with the clinic concept, including the requirement that patients come to the clinic daily for their methadone. Clinic hours often conflict with patients’ work schedules, and make it very difficult to take a vacation. In some areas of the country, the clinics are few and far between, requiring traveling many miles each day. The biggest and probably most important obstacle has been the stigma associated with being seen entering or exiting a methadone clinic. In an attempt to reduce that stigma, I present the six most common myths about methadone and explain why they are incorrect. Myth #1: Methadone is a substitute for heroin or prescription opioids. Methadone is a treatment for opioid addiction, not a substitute for heroin. Methadone is long-acting, requiring one daily dose. Heroin is short-acting, and generally takes at least three to four daily doses to prevent withdrawal symptoms from emerging. Myth #2: Patients who are on a stable dose of methadone, who are not using any other non-prescribed or illicit medications, are addicted to the methadone. Patients taking methadone are physically dependent on it, but not addicted to it. Methadone does not cause harm, and provides benefits. People with many common chronic illnesses are physically dependent on their medication to keep them well, such as insulin for diabetes, inhalers for asthma and blood pressure pills for hypertension. Myth #3: Patients who are stable on their methadone dose, who are not using other non-prescribed or illicit drugs, are not able to perform well in many jobs. People who are stable on methadone should be able to do any job they are otherwise qualified to do. A person stabilized on the correct dose is not sedated, in withdrawal or euphoric. The most common description of how a person feels on methadone is “normal.” Myth #4: Methadone rots teeth and bones. After 50 years of use, methadone remains a safe medication. There are side effects from taking methadone and other opioids, such as constipation and increased sweating. These are usually easily manageable. If patients engage in good dental hygiene, they should not have any dental problems. Myth #5: Methadone is not advisable in pregnant women. The evidence over the years has shown that a pregnant woman addicted to opioids has the best possible outcome for herself and her fetus if she takes either methadone or buprenorphine. A pregnancy’s outcomes are better for mother and newborn if the mother remains on methadone than if she tapers off and attempts to be abstinent during pregnancy. Methadone does not cause any abnormalities in the fetus and does not appear to cause cognitive or any other abnormalities in these children as they grow up. Babies born to mothers on methadone will experience neonatal abstinence syndrome, which occurs in most newborns whose mothers were taking opioids during pregnancy. This syndrome is treated and managed somewhat easily and outcomes for the newborn are good—it is not a reason for a pregnant woman to avoid methadone treatment. Mothers on methadone should breastfeed unless there is some other contraindication, such as being HIV-positive. Myth #6: Methadone makes you sterile. This is untrue. Methadone may lower serum testosterone in men, but this problem is easily diagnosed and treated. These myths, and the stigma of methadone treatment that accompanies them, are pervasive and persistent issues for methadone patients. They are often embarrassed to tell their other physicians, dentists and family members about their treatment. They may feel they are doing something wrong, when in fact they are doing something very positive for themselves and their loved ones. These misperceptions can only be corrected with more education for patients, families, health care providers and the general public. Edwin A. Salsitz, MD, FASAM, is Medical Director, Office-Based Opioid Therapy at Beth Israel Medical Center in New York.
Thursday, April 3, 2014
Frequency of Energy Drink Use Linked with Risk of Abusing Prescription Drugs By Join Together Staff | April 3, 2014 | College students who consume energy drinks are more likely than their peers who don’t use them to abuse prescription drugs, a new study concludes. The more energy drinks a student consumes, the greater their risk. The study included undergraduate and graduate college students, who completed a web-based survey about their pattern of energy drink and prescription stimulant use. They were asked about medications prescribed to them, as well as drugs they took without a prescription. The more energy drinks students consumed, the likelier they were to illicitly use prescription stimulants. All students who had a valid prescription for stimulant medications said they mixed energy drinks with their stimulants. This is discouraged, because it can increase side effects, News-Medical.net reports. The findings are published in Substance Abuse. “This article includes a needed review of the neurological effects of energy drink ingredients. It also provides practitioners with important information about the dangerous interactions that can occur when energy drinks are mixed with prescription stimulants or other pharmaceutical drugs,” lead author Dr. Conrad Woolsey said in a news release. “Ginseng, for example, should not be mixed with anti-depressant medications or prescription stimulants because this can cause dangerously high levels of serotonin (i.e., serotonin syndrome), which is known for causing rapid irregular heartbeats and even seizures.”
Posted by Marianne Karg at 1:27 PM
Thursday, March 20, 2014
Vaporizers Gain Popularity Among Marijuana Smokers By Join Together Staff | March 18, 2014 | A growing number of marijuana smokers are choosing to use vaporizers, which are similar to e-cigarettes, according to USA Today. The popularity of the devices is changing the way marijuana is packaged and sold in states where it is legal. The vaporizers, known as “vape pens,” are compact and portable. Steve DeAngelo, a marijuana entrepreneur and activist who founded the Harborside Health Center medical marijuana dispensary in Oakland, California, says his dispensary does about half of its business in raw marijuana leaf or flowers. The rest are sold as edibles or concentrates, some of which are prepackaged for use in vape pens. “The percentage of raw (pot) flowers we sell has been dropping steadily,” he said. “The percent of extracts and concentrates … has been rising steadily.” Some vape pens use concentrated marijuana extractions, while others use marijuana leaves and flowers. “This really portends the next generation of marijuana use,” John Lovell, a Sacramento attorney and lobbyist for the California Narcotics Officers’ Association and California Police Chiefs Association, told the newspaper. His group is concerned about the high-strength concentrates used in vape pens. Concentrates can be composed of as much as 80 percent or 90 percent THC, the psychoactive ingredient in marijuana. Others are concerned that vape pens allow teens to smoke marijuana without being detected, because the pens leave no odor.
Posted by Marianne Karg at 4:17 PM
Thursday, February 27, 2014
Advocates Urge FDA to Revoke Approval of Painkiller Zohydro By Join Together Staff | February 26, 2014 | More than 40 addiction treatment, health care and consumer groups are urging the Food and Drug Administration (FDA) to reverse its decision to approve the prescription painkiller Zohydro ER (extended release), CNN reports. The drug is a pure form of the painkiller hydrocodone. The FDA approved Zohydro ER in October for patients with pain that requires daily, around-the-clock, long-term treatment that cannot be treated with other drugs. Drugs such as Vicodin contain a combination of hydrocodone and other painkillers such as acetaminophen. Zohydro ER is set to become available in March, the article notes. In December 2012, a panel of experts assembled by the FDA voted against recommending approval of Zohydro ER. The panel cited concerns over the potential for addiction. Zohydro is designed to be released over time, and can be crushed and snorted by people seeking a strong, quick high. The opioid drug OxyContin has been reformulated to make it harder to crush or dissolve, but Zohydro does not include similar tamper-resistant features. In a letter to FDA Commissioner Dr. Margaret Hamburg, the coalition of health groups, wrote, “In the midst of a severe drug epidemic fueled by overprescribing of opioids, the very last thing the country needs is a new, dangerous, high-dose opioid. Too many people have already become addicted to similar opioid medications, and too many lives have been lost.” The health groups include the American Society of Addiction Medicine, Public Citizen Health Research Group, Phoenix House, the Hazelden Foundation, and Physicians for Responsible Opioid Prescribing. In December, 28 attorneys general wrote to Commissioner Hamburg, saying they believe the approval of Zohydro ER “has the potential to exacerbate our nation’s prescription drug abuse epidemic because this drug will be the first hydrocodone-only opioid narcotic that is reportedly five to ten times more potent than traditional hydrocodone products, and it has no abuse-deterrent properties.”
Posted by Marianne Karg at 12:37 PM
Thursday, February 6, 2014
DEA Joins Investigation Into Source of Deadly Heroin That Killed 22 In Western PA By Join Together Staff | January 29, 2014 The Drug Enforcement Administration has joined an investigation into the source of a batch of heroin that killed 22 people in western Pennsylvania, The Wall Street Journal reports. The heroin involved in some of the deaths contained the synthetic opiate fentanyl, often used during surgery. “We do have a good idea where it’s coming from,” Pennsylvania Attorney General Kathleen Kane said of the drug mix. “We’re trying to find the source and get them off the street before there are any more deaths.” Dr. Karl Williams, medical examiner for Allegheny County, said 15 overdose deaths in the county appeared to be linked to heroin and fentanyl. In an average week, there are five overdose deaths in the county. More nonfatal overdoses were also reported. Officials found bags of heroin mixed with fentanyl at the scene of overdose deaths stamped with the names “Theraflu” and “Bud Ice,” the article notes. While most heroin is a tan color, these bags of powder were pure white, Williams said. “Clearly, someone has mixed up a big dose of it,” he said. Some local law enforcement and health officials are concerned that warning drug users about the dangerous heroin mix will encourage them to seek it out for a more potent high. “A lot will chase it, and demand goes up,” Neil Capretto, Medical Director of Gateway Rehabilitation Center told the newspaper. “They will think those who died were just careless.”
Posted by Marianne Karg at 12:51 PM